301 related articles for article (PubMed ID: 2856902)
1. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective and nonselective beta-adrenergic blockade on mechanisms of exercise conditioning.
Wolfel EE; Hiatt WR; Brammell HL; Carry MR; Ringel SP; Travis V; Horwitz LD
Circulation; 1986 Oct; 74(4):664-74. PubMed ID: 2875812
[TBL] [Abstract][Full Text] [Related]
3. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
McLeod AA; Brown JE; Kuhn C; Kitchell BB; Sedor FA; Williams RS; Shand DG
Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612
[TBL] [Abstract][Full Text] [Related]
5. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
Riddell JG; Shanks RG
Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
[TBL] [Abstract][Full Text] [Related]
6. Cardioselectivity of cetamolol compared with atenolol and nadolol.
Klausner MA; Ventura DF; Coelho J; Mullane JF; Irwin C; Hitzenberger G; Magometschnigg D; Kaik G; Garg DC; Weidler DJ
J Clin Pharmacol; 1988 Jun; 28(6):495-504. PubMed ID: 2901435
[TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of the beta 1-selectivity of single doses of bisoprolol and atenolol.
Chang PC; van Veen S; Vermeij P; van Brummelen P
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S58-60. PubMed ID: 2439799
[TBL] [Abstract][Full Text] [Related]
8. Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.
Wilcox RG; Hampton JR
Br J Clin Pharmacol; 1982 Jun; 13(6):841-6. PubMed ID: 6124268
[TBL] [Abstract][Full Text] [Related]
9. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
Hansen O; Johansson BW; Nilsson-Ehle P
Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
[TBL] [Abstract][Full Text] [Related]
10. Evidence for cardiac beta 2-adrenoceptors in man.
Brown JE; McLeod AA; Shand DG
Clin Pharmacol Ther; 1983 Apr; 33(4):424-8. PubMed ID: 6299641
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
O'Callaghan WG; Laher MS; McGarry K; O'Brien E; O'Malley K
Br J Clin Pharmacol; 1983 Oct; 16(4):417-21. PubMed ID: 6138058
[TBL] [Abstract][Full Text] [Related]
12. Peripheral vascular effects of beta-adrenoceptor blockade: comparison of two agents.
Cooke ED; Maltz MB; Smith RE; Bowcock SA; Watkins CJ; Camm AJ
Br J Clin Pharmacol; 1987 Sep; 24(3):359-66. PubMed ID: 2889459
[TBL] [Abstract][Full Text] [Related]
13. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.
DiBianco R; Morganroth J; Freitag JA; Ronan JA; Lindgren KM; Donohue DJ; Larca LJ; Chadda KD; Olukotun AY
Am Heart J; 1984 Oct; 108(4 Pt 2):1121-7. PubMed ID: 6148872
[TBL] [Abstract][Full Text] [Related]
14. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
Kostis JB; Lacy CR; Krieger SD; Cosgrove NM
Am Heart J; 1984 Oct; 108(4 Pt 2):1131-6. PubMed ID: 6148873
[TBL] [Abstract][Full Text] [Related]
15. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
[TBL] [Abstract][Full Text] [Related]
16. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
[TBL] [Abstract][Full Text] [Related]
17. Cardio-protection afforded by β-blockade is maintained during resistance exercise.
Conviser JM; Ng AV; Rockey SS; Thomas DP
J Sci Med Sport; 2017 Feb; 20(2):196-201. PubMed ID: 27012728
[TBL] [Abstract][Full Text] [Related]
18. Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.
Bolli P; Müller FB; Linder L; Ji BH; Bühler FR
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S61-4. PubMed ID: 2439800
[TBL] [Abstract][Full Text] [Related]
19. A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.
Lipworth BJ; Irvine NA; McDevitt DG
Eur J Clin Pharmacol; 1991; 40(2):135-9. PubMed ID: 1676675
[TBL] [Abstract][Full Text] [Related]
20. Role of cardiac beta 2-receptors in cardiac responses to exercise in cardiac transplant patients.
Leenen FH; Davies RA; Fourney A
Circulation; 1995 Feb; 91(3):685-90. PubMed ID: 7828294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
